Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Brian Adams is Chief Legal Officer at Relay Therapeutics. OQRO lists 10 transactions filed with the SEC under this name, the latest on Jul 30, 2025, each linked to the official Form 4.
Chief Legal Officer
Disclosures on record
10
Companies involved
1
As of the latest filing on , Brian Adams reported holding 371,472 shares of Relay Therapeutics (RLAY), worth about $6.72M at the last close of $18 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Relay Therapeutics RLAY | 371,472 | 371K direct | $18 | $6.72M | Jul 29, 2025 |
Is this Brian Adams’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Relay TherapeuticsRLAY
10 disclosures · Oct 2024 – Jul 2025 · 10 sold
Jul 29, 2025Sold~$67Kdisclosed Jul 30
DetailsOfficial recordJul 28, 2025Sold~$6.1Kdisclosed Jul 30
DetailsOfficial recordApr 30, 2025Sold~$39Kdisclosed May 1
DetailsOfficial recordApr 28, 2025Sold~$5.2Kdisclosed May 1
DetailsOfficial recordMar 27, 2025Sold~$846disclosed Mar 31
DetailsOfficial recordJan 28, 2025Sold~$156Kdisclosed Jan 31
DetailsOfficial recordJan 30, 2025Sold~$92Kdisclosed Jan 31
DetailsOfficial recordDec 27, 2024Sold~$1.3Kdisclosed Dec 31
DetailsOfficial recordOct 28, 2024Sold~$9.9Kdisclosed Oct 30
DetailsOfficial recordSep 27, 2024Sold~$2.2Kdisclosed Oct 1
DetailsOfficial recordBrian Adams bought shares on the open market in 2020, and has not bought since 2020. Sales in each of the last 5 years.
Brian Adams reported 1 open-market purchase and 39 sales since 2020; purchases in 2020.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $366K7×7 trades |
| 2024 | — | $59K7×7 trades |
| 2023 | — | $294K10×10 trades |
| 2022 | — | $76K7×7 trades |
| 2021 | — | $1.22M8×8 trades |
| 2020 | $200K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jul 29, 2025, Brian Adams reported holding 371,472 shares of Relay Therapeutics (RLAY). At the last close of $18 on Nov 13, 2026, that is about $6.72M. This is the stake disclosed in filings, not a net worth.
Brian Adams bought shares on the open market in 2020, and has not bought since 2020. Sales in each of the last 5 years.
In SEC filings since 2020: the latest open-market purchase is from 2020; the latest open-market sale is from 2025.
Relay Therapeutics (RLAY), from 2020 to 2025: 1 purchase and 39 sales.
Brian Adams reported 1 open-market purchase and 39 sales here, 2020 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
